维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Wakeling AE"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Prospects for combining hormonal and nonhormonal growth factor inhibition显示文摘	Wakeling AE Nicholson RI Gee JM	2001	Clin Cancer Res2001，7，12：	1
2	A potent specific pure antiestrogen with clinical potntial 显示文摘	Wakeling AE Dukes M Bowler J	1991	Cancer Res1991，51，：	1
3	ZD1839 (Iressa) : an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy显示文摘	Wakeling AE Guy SP Woodburn JR	2002	Cancer Res2002，62，：	1
4	ZD1839 (iressa) : an orally active inhibitor of EGF signaling with potential for cancer therapy显示文摘	Wakeling AE Guy SP Woodburn JR	2002	Cancer Res2002，62，20：	1
5	ZD1839(Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy显示文摘	Wakeling AE Guy SP Woodburn JR Ashton SE Curry BJ Barker AJ	2002	Cancer Res2002，62，：	1
6	Epidermal growth factor receptor tyrosine kinase inhibitors显示文摘	Wakeling AE	2002	Curr Opin Pharm2002，2，4：	1
7	Non steroidal antioestrogens-receptor binding and biological response in rat uterus,rat mammary carcinmoma and human breast cancer cells显示文摘	Wakeling AE Valcaccia B Newbouh E	1984	J Steroid Biochem1984，20，：	1
8	ZD1839 (Iressa):An orally active inhibitor of EGF signaling with potential for cancer therapy显示文摘	Wakeling AE Guy SP Woodburn JR	2002	Cancer Res2002，62，：	1
9	ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy 显示文摘	Wakeling AE Guy SP Woodburn JR	2002	Cancer Res2002，62，20：	1
10	ZD1839 (Iressa):an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy显示文摘	Wakeling AE Guy SP Woodburn JR		0，，20：	1
11	Similarities and distinctions in the mode of action of different classes of antioestrogens显示文摘	Wakeling AE	2000	Endocr Relat Cancer2000，7，1：	1
12	Epidermal growth factor receptor tyrosine kinase inhibitors 显示文摘	Wakeling AE	2002	Curr Opin Pharmacol2002，2，4：	1
13	Non steroidal antioestrogens-receptor binding and biological response in rat uterus,rat mammary carcinmoma and human breast cancer cells显示文摘	Wakeling AE Valcaccia B Newboult E	1984	J Steroid Biochem1984，20，：	1
14	ZD1839(Iressa):an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy显示文摘	Wakeling AE Guy SP Woodburn JR	2002	Cancer Res2002，62，20：	1
15	Similarities and distinctions in the mode of action ofdifferent classes of antioestrogens显示文摘	Wakeling AE	2000	Endocr Relat Cancer2000，7，：	1
16	ZD1839 (Iressa) : an o- rally active inhibitor of epidermal growth factor signaling with po- tential for cancer therapy 显示文摘	Wakeling AE Guy SP Woodburn JR	2002	Cancer Res2002，62，：	1
17	Apotent specific pure antiestrogen with clinical potential显示文摘	Dukes M Bowler J	1991	Cancer Res1991，51，：	1
18	Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells显示文摘	Wakeling AE Newboult E Peters SW	1989	J Mol Endocrinol1989，2，3：	1
19	Apotent specific pure antiestrogen with clinical potential显示文摘	Dukes M Bowler J	1991	Cancer Res1991，1，15：	1
20	Estrogen-receptor binding and biologic activity of tamoxifen and its metabolites 显示文摘	Wakeling AE Slater SR	1980	Cancer Treat Rep1980，64，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示